The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype
Open accessAbstract
Introduction: The clinicopathologic features and prognostic predictors of radiological part‐solid lung adenocarcinomas were unclear. Methods: We retrospectively compared the clinicopathologic features and survival times of part‐solid tumors with those of pure ground glass nodules (pGGNs) and pure solid tumors treated with surgery at Fudan University Shanghai Cancer Center and evaluated the prognostic implications of consolidation‐to‐tumor ratio (CTR), solid component size, and tumor size for part‐solid lung adenocarcinomas. Results: A total of 911 patients and 988 pulmonary nodules (including 329 part‐solid nodules [PSNs], 501 pGGNs, and 158 pure solid nodules) were analyzed. More female patients (p = 0.015) and nonsmokers (p = 0.003) were seen with PSNs than with pure solid nodules. The prevalence of lymphatic metastasis was lower in patients with PSNs than in those with pure solid tumors (2.2% versus 27% [p < 0.001]). The 5‐year lung cancer–specific (LCS) recurrence‐free survival and LCS overall survival of patients with PSNs were worse than those of patients with pGGNs (p < 0.001 and p = .042, respectively) but better than those of patients with pure solid tumors ([p < 0.001 and p < 0.0001, respectively]). CTR (OR = 12.90; 95% confidence interval [CI]: 1.85–90.04), solid component size (OR = 1.45; 95% CI: 1.28–1.64), and tumor size (OR = 1.23; 95% CI: 1.15–1.31) could predict pathologic invasive adenocarcinoma for patients with PSNs. None of them could predict the prognosis. Patients receiving sublobar resection had prognoses comparable to those of patients receiving lobectomy (p = .178 for 5‐year LCS recurrence‐free survival and p = .319 for 5‐year LCS overall survival). The prognostic differences between patients with systemic lymph node dissection and those without systemic lymph node dissection were statistically insignificant. Conclusions: Part‐solid lung adenocarcinoma showed clinicopathologic features different from those of pure solid tumor. CTR, solid component size, and tumor size could not predict the prognosis. Part‐solid lung adenocarcinomas define one special clinical subtype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., Powell, C. A., Prokop, M., et al. (2017) · Radiology · doi:10.1148/radiol.2017161659 · Cited by 2,491
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
McWilliams, A., Tammemagi, M. C., Mayo, J. R., Roberts, H., Liu, G., Soghrati, K., Yasufuku, K., Martel, S., Laberge, F., Gingras, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214726 · Cited by 1,414
Naidich, D. P., Bankier, A. A., MacMahon, H., Schaefer-Prokop, C. M., Pistolesi, M., Goo, J. M., Macchiarini, P., Crapo, J. D., Herold, C. J., Austin, J. H., et al. (2013) · Radiology · doi:10.1148/radiol.12120628 · Cited by 1,000
Travis, W. D., Asamura, H., Bankier, A. A., Beasley, M. B., Detterbeck, F., Flieder, D. B., Goo, J. M., MacMahon, H., Naidich, D., Nicholson, A. G., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.03.025 · Cited by 722
Horeweg, N., van Rosmalen, J., Heuvelmans, M. A., van der Aalst, C. M., Vliegenthart, R., Scholten, E. T., ten Haaf, K., Nackaerts, K., Lammers, J.-W. J., Weenink, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70389-4 · Cited by 526
Nakamura, K., Saji, H., Nakajima, R., Okada, M., Asamura, H., Shibata, T., Nakamura, S., Tada, H., & Tsuboi, M. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp156 · Cited by 525
Asamura, H., Hishida, T., Suzuki, K., Koike, T., Nakamura, K., Kusumoto, M., Nagai, K., Tada, H., Mitsudomi, T., Tsuboi, M., et al. (2013) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.12.047 · Cited by 346
Tsutani, Y., Miyata, Y., Nakayama, H., Okumura, S., Adachi, S., Yoshimura, M., & Okada, M. (2014) · Chest · doi:10.1378/chest.13-1094 · Cited by 308
Liu, S., Wang, R., Zhang, Y., Li, Y., Cheng, C., Pan, Y., Xiang, J., Zhang, Y., Chen, H., & Sun, Y. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4907 · Cited by 235
Self-citation
Metadata
- Authors
- Ye, T., Deng, L., Wang, S., Xiang, J., Zhang, Y., Hu, H., Sun, Y., Li, Y., Shen, L., Xie, L., Gu, W., Zhao, Y., Fu, F., Peng, W., & Chen, H.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 14
- Issue
- 4
- Pages
- 617-627
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2908887191
- Cited by
- 269
- References
- 19
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype. https://app.cochat.ai/papers/10.1016/j.jtho.2018.12.030
- The paper
- Ye, T., Deng, L., Wang, S., Xiang, J., Zhang, Y., Hu, H., Sun, Y., Li, Y., Shen, L., Xie, L., Gu, W., Zhao, Y., Fu, F., Peng, W., & Chen, H. (2019). Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2018.12.030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.